Biona Herbal Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -4.14%
(FY 2022)
- Ebitda 100.00%
(FY 2022)
- Net Worth -0.09%
(FY 2022)
- Total Assets -26.80%
(FY 2022)
About Biona Herbal Research Centre
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Eswara Nallamilli, Mahima Datla, and Rudaraju Kumar serve as directors at the Company.
- CIN/LLPIN
U73100TG2000PTC035018
- Company No.
035018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2000
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biona Herbal Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eswara Nallamilli  | Director | 03-Sep-2001 | Current |
| Mahima Datla | Director | 31-Jul-2000 | Current |
| Rudaraju Kumar | Director | 21-Nov-2017 | Current |
Financial Performance and Corporate Structure Insights of Biona Herbal Research Centre.
Biona Herbal Research Centre Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 4.14% decrease in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biona Herbal Research Centre?
In 2021, Biona Herbal Research Centre had a promoter holding of 99.60% and a public holding of 0.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vaxenic India Private Limited
Active 9 years 9 monthsEswara Nallamilli, Mahima Datla and 1 more are mutual person
Be Pharmaceuticals Private Limited
Active 13 years 2 monthsMahima Datla and Rudaraju Kumar are mutual person
Lacto-Cosmetics (Hyd) Pvt Ltd
Active 41 years 16 daysEswara Nallamilli, Mahima Datla and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biona Herbal Research Centre?
Unlock and access historical data on people associated with Biona Herbal Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biona Herbal Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biona Herbal Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
